期刊文献+

靶向SET的shRNA真核表达质粒的构建及鉴定

Construction of eukaryotic vectors expressing shRNAs targeting the set gene
下载PDF
导出
摘要 目的:针对PP2A内源性抑制剂SET基因的不同部位,构建靶向SET的shRNA真核表达质粒,鉴定并筛选出最佳抑制效率的表达质粒.方法:针对SET基因的不同部位设计4对短发卡RNA(shRNA)的寡核苷酸片段,克隆到真核表达载体pGPU6中,构建靶向SET的shRNA真核表达质粒pGPU6/GFP/Neo-SET-shRNA-1、2、3、4.利用脂质体转染人胃癌细胞株BGC-823,Western blot法检测并筛选最佳抑制效率的shRNA表达质粒.结果:4个靶向SET的shRNA真核表达质粒pGPU6/GFP/Neo-SET-shRNA-1、2、3、4经限制性酶切和测序证实基因已正确插入,荧光显示转染效率可达到80%以上.Western blot法证实pGPU6/GFP/Neo-SET-shRNA-3明显降低BGC-823细胞内SET蛋白的表达.pGPU6/GFP/Neo-SET-shRNA-3对SET蛋白表达的抑制效应在72h达到最强.结论:成功构建靶向SET的shRNA真核表达质粒pGPU6/GFP/Neo-SET-shRNA-1、2、3、4,并筛选出最佳抑制效率的表达质粒,为今后研究SET在胃癌中的作用机理奠定了基础. AIM:To construct eukaryotic vectors expressing short hairpin RNAs(shRNAs) targeting the set gene which encodes an endogenous inhibitor of PP2A.METHODS:Four oligonucleotides targeting the SET gene were synthesized and cloned into the eukaryotic expression plasmid pGPU6.The resulting four recombinant plasmids,pGPU6/GFP/Neo-SET-shRNA-1,2,3 and 4,were introduced into BGC-823 cells by lipofectamine-mediated transfection.The gene silencing eff iciency was measured by Western blot RESULTS:DNA sequencing and enzyme digestion analysis confirmed the identity of the four recombinant shRNA expression vectors.Immunofluorescsence demonstrated that transfection efficiency was above 80%.Transfection of pGPU6/GFP/Neo-SET-shRNA-3 significantly knocked down the expression of SET protein as revealed by Western blot.The silencing effect of pGPU6/GFP/Neo-SET-shRNA-3 on the expression of SET protein was most remarkable at 72 h after transfection.CONCLUSION:Eukaryotic vectors expressing shRNAs targeting the set gene have been constructed successfully and can be used to study the role of SET in gastric cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第24期2521-2526,共6页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30870981 No.81001082 No.81000884~~
关键词 SET 短发卡RNA 胃癌 蛋白磷酸酶2A Set gene Short hairpin RNA Gastric cancer PP2A
  • 相关文献

参考文献32

  • 1von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. Mol Cell Biol 1992; 12: 3346-3355 PubMed.
  • 2Nagata K, Kawase H, Handa H, Yano K, Yamasaki M, Ishimi Y, Okuda A, Kikuchi A, Matsumoto K. Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci U S A 1995; 92: 4279-4283 PubMed DOI.
  • 3Li M, Makkinje A, Damuni Z. The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 1996; 271: 11059-11062 PubMed DOI.
  • 4Vaesen M, Barnikol-Watanabe S, G?tz H, Awni LA, Cole T, Zimmermann B, Kratzin HD, Hilschmann N. Purification and characterization of two putative HLA class II associated proteins: PHAPI and PHAPII. Biol Chem Hoppe Seyler 1994; 375: 113-126 PubMed DOI.
  • 5Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 2001; 104: 119-130 PubMed DOI.
  • 6Cervoni N, Detich N, Seo SB, Chakravarti D, Szyf M. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem 2002; 277: 25026-25031 PubMed DOI.
  • 7NCCN. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. 2006-01; cited 2011-08. Available from: www.nccn.org.
  • 8Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol 2001; 30: 1415-1425 PubMed DOI.
  • 9刘丽江,张应天.胃癌淋巴结微转移的组织学诊断及其间质反应的研究[J].中华病理学杂志,2000,29(5):339-342. 被引量:10
  • 10吕伟,陈凛.胃癌分子靶向治疗的现状与进展[J].世界华人消化杂志,2007,15(25):2672-2678. 被引量:20

二级参考文献96

共引文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部